Across Canada, patients are returning to healthcare facilities to receive non-emergent care, postponed or otherwise. Yet the pandemic is far from over, and there are still many unknowns about when it’s safe to return and whether in-person visits will again become the standard or if healthcare will shift to a different model. ZS surveyed 261 Canadian physicians to learn their perspectives on delivery of care, tele and virtual health, and how this will affect pharma’s role, now and in the future.

 

See below to download the full report.